NFE2L2 and glioblastoma: Targeting NFE2L2 regulates the expression of TFRC, FTH1 and GPX4, induces the increase of unstable iron and the depletion of GPX4, which is an important mechanism of orexin‐A‐mediated GBM ferroptosis.